BioMark Diagnostics Inc.
BUX
Rank in Stocks
#26610
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Share Price
$0.34495034
Last synced: 2026-10-16
Market Cap
$36.73M
Change (1 day)
-4.08%
Change (1 year)
41.11%
Country
CA
Trade BioMark Diagnostics Inc. (BUX)
Category
Healthcare
Number of shares outstanding for BioMark Diagnostics Inc. (BUX)
Number of shares outstanding as of October 2026: 0
According to BioMark Diagnostics Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of October 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for BioMark Diagnostics Inc. (BUX) from 2026 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 371.00M | - |
US
|
|
| 705.30M | - |
US
|
|
| 143.28M | - |
US
|
|
| - | - |
CN
|
|
| 282.00M | - |
US
|
